Methodological considerations on estimating medication adherence from self-report, electronic monitoring and electronic healthcare databases using the TEOS framework

被引:13
作者
Dima, Alexandra L. [1 ]
Allemann, Samuel S. [2 ]
Dunbar-Jacob, Jacqueline [3 ]
Hughes, Dyfrig A. [4 ]
Vrijens, Bernard [5 ,6 ]
Wilson, Ira B. [7 ]
机构
[1] Inst Recerca St Joan de Deu, Res & Dev Unit, Barcelona, Spain
[2] Univ Basel, Pharmaceut Care Res Grp, Basel, Switzerland
[3] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA
[4] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales
[5] Univ Liege, AARDEX Grp, Liege, Belgium
[6] Univ Liege, Dept Publ Hlth, Liege, Belgium
[7] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA
基金
美国国家卫生研究院;
关键词
adherence; methodology; pharmacotherapy; RECOMMENDATIONS; VALIDATION; ROAD;
D O I
10.1111/bcp.15375
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims Measuring adherence to medication is complex due to the diversity of contexts in which medications are prescribed, dispensed and used. The Timelines-Events-Objectives-Sources (TEOS) framework outlined a process to operationalize adherence. We aimed to develop practical recommendations for quantification of medication adherence using self-report (SR), electronic monitoring (EM) and electronic healthcare databases (EHD) consistent with the TEOS framework for adherence operationalization. Methods An adherence methodology working group of the International Society for Medication Adherence (ESPACOMP) analysed implications of the process of medication adherence for all data sources and discussed considerations specific to SR, EM and EHD regarding the information available on the prescribing, dispensing, recommended and actual use timelines, the four events relevant for distinguishing the adherence phases, the study objectives commonly addressed with each type of data, and the potential sources of measurement error and quality criteria applicable. Results Four key implications for medication adherence measurement are common to all data sources: adherence is a comparison between two series of events (recommended and actual use); it refers to one or more specific medication(s); it applies to regular repeated events coinciding with known recommended dosing; and it requires separate measurement of the three adherence phases for a complete picture of patients' adherence. We propose recommendations deriving from these statements, and aspects to be considered in study design when measuring adherence with SR, EM and EHD using the TEOS framework. Conclusion The quality of medication adherence estimates is the result of several design choices that may optimize the data available.
引用
收藏
页码:1918 / 1927
页数:10
相关论文
共 41 条
  • [31] Thorndike R.M., 2009, MEASUREMENT EVALUATI, V8th
  • [32] Tourangeau R., 2000, The psychology of survey response, V1st ed., DOI [DOI 10.1017/CBO9780511819322, https://doi.org/10.1017/CBO9780511819322]
  • [33] Voils CI, 2011, J CLIN EPIDEMIOL, V64, P250, DOI 10.1016/j.jclinepi.2010.07.014
  • [34] Comparing compliance patterns between randomized treatments
    Vrijens, B
    Goetghebeur, E
    [J]. CONTROLLED CLINICAL TRIALS, 1997, 18 (03): : 187 - 203
  • [35] Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories
    Vrijens, Bernard
    Vincze, Gabor
    Kristanto, Paulus
    Urquhart, John
    Burnier, Michel
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7653): : 1114 - 1117
  • [36] A new taxonomy for describing and defining adherence to medications
    Vrijens, Bernard
    De Geest, Sabina
    Hughes, Dyfrig A.
    Przemyslaw, Kardas
    Demonceau, Jenny
    Ruppar, Todd
    Dobbels, Fabienne
    Fargher, Emily
    Morrison, Valerie
    Lewek, Pawel
    Matyjaszczyk, Michal
    Mshelia, Comfort
    Clyne, Wendy
    Aronson, Jeffrey K.
    Urquhart, J.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (05) : 691 - 705
  • [37] STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies
    Wang, Shirley, V
    Pinheiro, Simone
    Hua, Wei
    Arlett, Peter
    Uyama, Yoshiaki
    Berlin, Jesse A.
    Bartels, Dorothee B.
    Kahler, Kristijan H.
    Bessette, Lily G.
    Schneeweiss, Sebastian
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [38] A Proposal for Quality Standards for Measuring Medication Adherence in Research
    Williams, Ann Bartley
    Amico, K. Rivet
    Bova, Carol
    Womack, Julie A.
    [J]. AIDS AND BEHAVIOR, 2013, 17 (01) : 284 - 297
  • [39] Validation of a New Three-Item Self-Report Measure for Medication Adherence
    Wilson, Ira B.
    Lee, Yoojin
    Michaud, Joanne
    Fowler, Floyd J., Jr.
    Rogers, William H.
    [J]. AIDS AND BEHAVIOR, 2016, 20 (11) : 2700 - 2708
  • [40] Improving the self-report of HIV antiretroviral medication adherence: Is the glass half full or half empty?
    Wilson I.B.
    Carter A.E.
    Berg K.M.
    [J]. Current HIV/AIDS Reports, 2009, 6 (4) : 177 - 186